drugset / Trial / NCT01006785
Efficacy and Safety of DLBS1425 in Subjects With Advanced/Metastatic Breast Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
The purposes of this study are : * to investigate the safety and clinical efficacy of sole therapy with DLBS1425 in suppressing disease-(tumour) progression in subjects with advanced/metastatic breast cancer; and * to determine the minimal effective and safe dose of DLBS1425 in the therapy of advanced/metastatic breast cancer
Timeline
- Start
- 2009-08
- Primary completion
- 2012-03
- Completion
- 2012-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DLBS1425 | Unknown | 150 mg | — |
| Subject | DLBS1425 | Unknown | 300 mg | — |